DEL BELLO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.554
EU - Europa 3.999
AS - Asia 1.805
Continente sconosciuto - Info sul continente non disponibili 43
SA - Sud America 31
AF - Africa 14
OC - Oceania 10
Totale 14.456
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.277
CN - Cina 1.475
IT - Italia 1.093
DE - Germania 753
PL - Polonia 640
UA - Ucraina 352
SE - Svezia 292
CA - Canada 273
GB - Regno Unito 222
FI - Finlandia 196
SG - Singapore 159
FR - Francia 153
IE - Irlanda 98
CZ - Repubblica Ceca 69
BE - Belgio 44
EU - Europa 38
IN - India 32
VN - Vietnam 32
IR - Iran 20
NL - Olanda 18
RU - Federazione Russa 17
TR - Turchia 15
PK - Pakistan 14
JP - Giappone 13
KR - Corea 13
EG - Egitto 11
AU - Australia 10
RO - Romania 9
UY - Uruguay 9
HK - Hong Kong 8
MY - Malesia 8
BR - Brasile 7
GR - Grecia 7
PE - Perù 7
PT - Portogallo 7
BY - Bielorussia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AT - Austria 5
CL - Cile 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
HU - Ungheria 3
RS - Serbia 3
CO - Colombia 2
DK - Danimarca 2
ID - Indonesia 2
IL - Israele 2
IS - Islanda 2
MX - Messico 2
NG - Nigeria 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BS - Bahamas 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
IQ - Iraq 1
JM - Giamaica 1
KH - Cambogia 1
LT - Lituania 1
NO - Norvegia 1
PS - Palestinian Territory 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 14.456
Salva come PNG Salva come JPEG
Città #
Fairfield 925
Jacksonville 863
Woodbridge 819
Chandler 602
Warsaw 522
Ann Arbor 517
Ashburn 517
Houston 502
Wilmington 458
Seattle 362
Cambridge 292
Camerino 284
Nanjing 275
Toronto 219
Dearborn 203
Beijing 152
San Mateo 140
Lawrence 129
Princeton 129
Boardman 127
Kraków 113
Helsinki 109
Nanchang 103
Dublin 98
Columbus 97
Ogden 96
Singapore 92
Düsseldorf 83
Shanghai 69
New York 67
Shenyang 65
London 64
Kunming 57
Brno 56
Jiaxing 56
Guangzhou 55
Lachine 50
Jinan 47
San Diego 44
Tianjin 43
Brussels 42
Hebei 39
Bremen 38
Changsha 37
Milan 37
Centro 36
Los Angeles 33
Philadelphia 31
Dong Ket 29
Redwood City 27
Wuhan 26
Venezia 25
Zhengzhou 25
Hangzhou 24
Ningbo 24
Hefei 21
Leawood 21
Munich 21
Perugia 21
Falls Church 19
Monmouth Junction 19
Taizhou 18
Chicago 17
Orange 17
Nürnberg 16
Pesaro 15
Venice 15
Washington 15
Buffalo 14
Jinhua 14
Tulsa 14
Rome 13
Verona 13
Changchun 12
Kocaeli 12
Lanzhou 12
Norwalk 12
Olomouc 12
Fuzhou 11
Strasbourg 11
Tappahannock 11
Yiwu 11
Ardabil 10
Auburn Hills 10
Binzhou 10
Buti 10
Macerata 10
Old Bridge 10
West Jordan 10
Augusta 9
Baotou 9
Montevideo 9
Ancona 8
Dronten 8
Hounslow 8
Seoul 8
Wuxi 8
Chongqing 7
Council Bluffs 7
Hanover 7
Totale 10.539
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists 256
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 255
An Efficient Lewis Acid Catalyzed Povarov Reaction for the One-Pot Stereocontrolled Synthesis of Polyfunctionalized Tetrahydroquinolines 253
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 244
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation 237
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine 231
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 230
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 226
Exploring the Role of N6‐Substituents in Potent Dual Acting 5'‐C‐Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 221
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 214
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 203
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 203
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 202
Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms 201
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 190
1,4-Dioxane Nucleus as a Suitable Scaffold for the Characterization of Different Receptor Systems 189
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 188
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 181
1,4-Dioxane ring as a promising template of novel 5-HT1A full agonists 179
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 175
Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms 170
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway 170
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 163
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 159
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 157
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation 156
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 154
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 152
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 152
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 151
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats 149
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 149
Effects of imidazoline I2 receptor ligands on acute nociception in rats 146
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition 145
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 145
Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane 144
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation 142
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 142
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 138
Potent muscarinic antagonists bearing 1,4-dioxane scaffold 136
Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma 135
Synthesis of Triazole-Linked Analogues of c‐di-GMP and Their Interactions with Diguanylate Cyclase 135
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 135
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 133
null 132
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect 131
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 130
null 129
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 127
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 125
Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility 125
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold 124
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 123
Front Cover, European Journal of Medicinal, Issue 146, 25 February 2018. 120
Might Adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? 118
Complessi di rame(I) con leganti tris(azolil)borati e fosfine monodentate: sintesi e studi biologici 114
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 113
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 112
Fruitful Adrenergic alpha(2C)-Agonism/alpha(2A)-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence 108
New insights in Au-NHCs complexes as anticancer agents 108
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 107
From benzodioxane to 1,4-dioxane scaffold in the design of 5-HT1A serotoninergic full agonists from α1-adrenergic antagonists 106
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 105
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 104
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 104
Adenosine receptors as promising targets for the management of ocular diseases 104
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 101
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 100
Molecular determinants in the binding of novel 1,4-benzodioxan-related α1D-adrenergic receptor antagonists: a computational study 99
BIOLOGICAL PROFILE AND BIOAVAILABILITY OF IMIDAZOLINE COMPOUNDS AFFECT THEIR MODULATORY ACTIVITY ON MORPHINE TOLERANCE 99
Trekking through receptor chemistry 95
Allyphenyline analogues potentially useful in the management of chronic pain and opioid addiction. 95
Effects of allyphenyline on chronic alcohol intoxication model 94
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9.From 1,4-benzodioxan to 1,4-dioxane ring as a promising template of novel alpha(1D)-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 94
Imidazoline nucleus as a biologically versatile scaffold 93
Design and synthesis of novel imidazoline derivatives potentially targeting dopamine receptors 92
Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel alpha1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and alpha1d computational study 91
Copresence of 1,4-dioxane and quinuclidine nuclei in the design of novel muscarinic antagonists 89
Might adrenergic α2C-agonist/α2A-antagonist become a novel therapeutic multitarget tool for morphine chronic treatment of pain? 89
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 89
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 87
Hybrid molecules from xanomeline and 77-LH-28-1 as potential novel M1 muscarinic agonists 86
Aminopyrimidines as inhibitors of the Wnt signalling pathway 86
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 86
Might the observed alpha2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 85
Enantioselective interactions to improve adrenergic α2C-agonism/α2A-antagonism 85
Enantiomers of 6,6-diphenyl-1,4-dioxane derivatives to highlight stereochemical requirements for selective alpha1D-AR and 5- HT1A receptor recognition 85
NOVEL IMIDAZOLINE MOLECULES INSPIRED BY THE PHARMACOLOGICAL PROFILE OF AGMATINE AS POTENTIAL TOOLS IN MANAGING OPIOID ADDICTION 85
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 85
MORPHINE TOLERANCE MODULATION INDUCED BY alpha2-ADRENERGIC OR/AND I2 IMIDAZOLINE BINDING SITES LIGANDS 83
4WD to Travel Inside the 5-HT1A Receptor World 82
Structural motives of imidazoline molecules favouring the serotonin 5-HT1A receptor activation 80
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 79
Activation of primary amines by copper(I)-based Lewis acid promoters in the solventless synthesis of secondary propargylamines 79
Alpha2C-adrenoceptor modulators: a patent review 77
Novel α1-adrenoreceptor antagonists related to openphendioxan: biological evaluation and α1d computational study 75
Synergic stimulation of serotonin 5-HT1A receptor and α2-adrenoceptors for neuropathic pain relief: Preclinical effects of 2-substituted imidazoline derivatives 74
Novel muscarinic antagonists designed on the 1,4-dioxane scaffold 70
Design, synthesis, reactivity, biological and catalytic applications of functionalized bis(pyrazolyl)acetate copper complexes 69
Efficient Lewis Acid Systems for the A3 Coupling reaction 69
Totale 13.332
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.984
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.633 0 120 307 474 162 340 306 280 171 169 93 211
2020/20212.642 131 242 196 239 172 171 345 112 213 158 430 233
2021/20221.428 122 359 38 58 93 63 46 111 122 165 85 166
2022/20231.867 232 71 89 237 186 214 20 118 360 106 152 82
2023/20241.608 195 94 131 52 68 175 76 57 159 62 43 496
2024/2025329 241 88 0 0 0 0 0 0 0 0 0 0
Totale 14.924